Aviragen Therapeutics (AVIR) Tops Q1 EPS by 1c

Aviragen Therapeutics (NASDAQ: AVIR) reported Q1 EPS of ($0.40), $0.01 better than the analyst estimate of ($0.41).

For earnings history and earnings-related data on Aviragen Therapeutics (AVIR) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• JPMorgan Starts Kanzhun Ltd (2076:HK) at Overweight
• Morgan Stanley Downgrades Repsol SA (REP:SM) (REPYY) to Equalweight